Literature DB >> 9354262

Sequence analysis of the gene encoding the capsid protein of the Snow Mountain human calicivirus.

A D King1, K Y Green.   

Abstract

Snow Mountain virus (SMV) is the reference strain for serotype 3 as determined by immune electron microscopy of the human caliciviruses that are associated with epidemic gastroenteritis. In order to establish the genetic relationship of its capsid protein with those from other human caliciviriuses, the sequence of the open reading frame 2 (ORF2) encoding the SMV capsid protein was determined. The SMV ORF2 sequence was 1626 nucleotides in length and the deduced protein of 542 amino acids had a calculated molecular weight of 59.2 kD. The SMV capsid sequence showed approximately 48 and 77% amino acid sequence identity with the capsid proteins of the Norwalk (serotype 1) and Hawaii (serotype 2) human calicivirus reference strains, respectively, a finding consistent with its serotypic distinctiveness. Furthermore, the predicted amino acid sequence of the SMV capsid was found to share highest sequence identity (98%) with the Melksham human calicivirus in database searches.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354262     DOI: 10.1023/a:1007953126436

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  7 in total

1.  Capsid diversity in small round-structured viruses: molecular characterization of an antigenically distinct human enteric calicivirus.

Authors:  S M Green; P R Lambden; E O Caul; C R Ashley; I N Clarke
Journal:  Virus Res       Date:  1995-08       Impact factor: 3.303

2.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

3.  Sequence diversity of small, round-structured viruses in the Norwalk virus group.

Authors:  J Wang; X Jiang; H P Madore; J Gray; U Desselberger; T Ando; Y Seto; I Oishi; J F Lew; K Y Green
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Sequence and genome organization of a human small round-structured (Norwalk-like) virus.

Authors:  P R Lambden; E O Caul; C R Ashley; I N Clarke
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

5.  A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent.

Authors:  D M Morens; R M Zweighaft; T M Vernon; G W Gary; J J Eslien; B T Wood; R C Holman; R Dolin
Journal:  Lancet       Date:  1979-05-05       Impact factor: 79.321

6.  Molecular characterization of Hawaii virus and other Norwalk-like viruses: evidence for genetic polymorphism among human caliciviruses.

Authors:  J F Lew; A Z Kapikian; J Valdesuso; K Y Green
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

7.  Molecular characterization of a human calicivirus with sequence relationships closer to animal caliciviruses than other known human caliciviruses.

Authors:  D O Matson; W M Zhong; S Nakata; K Numata; X Jiang; L K Pickering; S Chiba; M K Estes
Journal:  J Med Virol       Date:  1995-02       Impact factor: 2.327

  7 in total
  4 in total

1.  Capsid protein diversity among Norwalk-like viruses.

Authors:  J Green; J Vinje; C I Gallimore; M Koopmans; A Hale; D W Brown; J C Clegg; J Chamberlain
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Snow Mountain virus genome sequence and virus-like particle assembly.

Authors:  Vance P Lochridge; Michele E Hardy
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

3.  Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.

Authors:  Patrick R Harrington; Lisa Lindesmith; Boyd Yount; Christine L Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Authors:  Noritoshi Kitamoto; Tomoyuki Tanaka; Katsurou Natori; Naokazu Takeda; Shuji Nakata; Xi Jiang; Mary K Estes
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.